自噬在恶性肿瘤中的研究进展_张露.docVIP

·1018· 现代医药卫生2016年4月第32卷第7期 J Mod Med Health，April 2016，Vol.32，No.7  poxia-ssociated epithelial-to-mesenchymal transition and metastasis me-diated by met signaling pathway[J]. Cancer Cell，2012，21（1）：66-81. Luo J，Meng C，Tang Y，et al. miR-132/212 cluster inhibits the growth of lung cancer xenografts in nude mice[J]. Int J Clin Exp Med，2014，7（11）： 4115-4122. Wang N，Liang H，Zhou Y，et al. miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC[J]. PLoS One，2014，9（8）：e105570. Guan P，Yin Z，Li X，et al. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues[J]. J Exp Clin Cancer Res，2012，31：54. Forde PM，Ettinger DS. Targeted therapy for non-small-cell lung cancer：past，present and future [J]. Expert Rev Anticancer Ther，2013，13 （6）： 745-758. Zheng W，Nurmi H，Appak S，et al. Angiopoietin 2 regulates the transfor-mation and integrity of lymphatic endothelial cell junctionset [J]. Genes Dev，2014，28（14）：1592-1603. Albini A，Noonan DM. Angiopoietin2 and Tie-2： tied to lymphangiogene-sis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy[J]. J Natl Cancer Inst，2012，104（6）：429-431. Coffelt SB，Tal AO，Scholz A，et al. Angiopoietin-2 Regulates Gene Ex- pression in TIE-2- Expressing Monocytes and Augments Their Inherent Proangiogenic Functions[J]. Cancer Res，2010，70（13）：5270-5280. [34] Holopainen T，Saharinen P，D′ Amico G，et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis[J]. Natl Cancer Inst，2012，104（6）：461-475. Mazzieri R，Pucci F，Moi D，et al. Targeting the ANG-2/TIE-2 axis inhi- bits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells [J]. Cancer Cell，2011，19 （4）： 512-526. [36] Vasudeb NS，Reyonlds AR. Anti-angiogenic therapy for cancer：current progress，unresolved questions and future directions [J]. Angiogenesis，2014，17（3）：471-494.